VR Logo

MiMedx Group Inc (MDXG) download report


Healthcare | Biotechnology & Pharma Research

MiMedx Group Inc (MDXG) Premium Coverage

53 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare.

IPO Date: 22-Aug-2007

CEO & Director: Mr. Timothy R. Wright MBA

Chief Financial Officer: Mr. Peter Martin Carlson CPA

Listing: NASDAQ: MDXG

Country: United States

Headquarters: Marietta, GA

Website: https://www.mimedx.com

Key Facts

Market cap: $404.67 Mln

Revenue (TTM): $257.54 Mln

Earnings (TTM): $-12.51 Mln

Cash: $75.68 Mln

Total Debt: $48.24 Mln

Insider's Holding: 1.98%

Liquidity: Low

52 Week range: $3.04 - 15.99

Shares outstanding: 113,353,000

10 Years Aggregate:

  • CFO: $148.98 Mln
  • EBITDA: $89.37 Mln
  • Net Profit: $-6.81 Mln

Stock Performance

Time Period MiMedx Group (MDXG) S&P BSE Sensex S&P Small-Cap 600
YTD-40.89-9.18-18.78
1 month-6.79-4.78-8.00
3 months-24.20-9.66-13.65
1 Year-71.460.81-17.19
3 Years-4.1210.336.10
5 Years-24.9311.345.87
10 Years5.4511.749.84
As on 01-Jul-2022
Year MiMedx Group (MDXG) S&P Small-Cap 600 S&P BSE Sensex
2021-33.4825.2721.99
202019.799.5715.75
2019323.4620.8614.38
2018-85.65-9.705.87
201742.3311.7327.91
2016-5.4424.741.95
2015-18.73-3.36-5.03